Purine Nucleoside Phosphorylase Deficiency: Clinical Trials

3 trials for Purine Nucleoside Phosphorylase Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Purine Nucleoside Phosphorylase Deficiency: new trials by email Literature Review of Purine Nucleoside Phosphorylase Deficiency trials Research Report on Purine Nucleoside Phosphorylase Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
AMPD3, OMIM*102772, AMP Deaminase Deficiency, AK1, OMIM *103000, Adenylate Kinase Deficiency
RecruitingNational Human Genome Research Institute (NHGRI)9992023-12-192026-08-19
Longitudinal Study of Neurodegenerative Disorders
Palliative Care, Hematopoetic Stem Cell Transplantation - MLD, Krabbe Disease
RecruitingUniversity of Pittsburgh15002012-01-112026-02-09
Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
Allogeneic Bone Marrow Transplantation, Cyclosporine, Laboratory Biomarker Analysis - Adenosine Deaminase Deficiency, Autosomal Recessive Disorder
Phase 1CompletedFred Hutchinson Cancer Center61997-08-112019-07-29

Narrower conditions

ADA2 protein, human (1)  ·  Adenine phosphoribosyltransferase deficiency (1)  ·  Adenosine monophosphate deaminase deficiency (1)  ·  Adenylosuccinate lyase deficiency (1)  ·  Anemia (1)  ·  Arts syndrome (1)  ·  Beta-Ureidopropionase Deficiency (1)  ·  Charcot-Marie-Tooth Disease (1)  ·  Dihydropyrimidinase Deficiency (1)  ·  Dihydropyrimidine Dehydrogenase Deficiency (1)  ·  Gaucher Disease (1)  ·  Genee-Wiedemann syndrome (1)  ·  Hemolysis (1)  ·  Hyper-IgM Immunodeficiency Syndrome (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Genetic Diseases, X-Linked (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Central Nervous System Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Heredodegenerative Disorders, Nervous System (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Metabolic Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Nervous System Diseases (2)  ·  Neurodegenerative Diseases (2)

Interventions

Cyclosporine (1)  ·  Cyclosporins (1)  ·  Mycophenolic Acid (1)  ·  Palliative Care (1)  ·  Whole-Body Irradiation (1)

Sponsors

Fred Hutchinson Cancer Center (1)  ·  National Human Genome Research Institute (NHGRI) (1)  ·  University of Pittsburgh (1)

Countries

United States (3)

Top investigators

Lauri Burroughs (1)  ·  Oleg A Shchelochkov, M.D. (1)

NIH funding

P01HL036444 (1), P30CA015704 (1)